The impact of opioid administration on the incidence of postanaesthetic colic in horses

Effective management of postoperative pain is essential to ensure patient welfare, reduce morbidity and optimize recovery. Opioids are effective in managing moderate to severe pain in horses but concerns over their adverse effects on gastrointestinal (GI) motility and associated increased colic risk limit their widespread use. Studies investigating the impact of systemic opioids on both GI motility and colic incidence in horses have yielded inconclusive outcomes. Therefore, this retrospective study aims to assess the influence of systemic administration of butorphanol, morphine, and methadone on post-anaesthetic colic (PAC) incidence. Horses undergoing general anaesthesia for non-gastrointestinal procedures that were hospitalized for at least 72 h post-anaesthesia were included in this study. Anaesthetised horses were stratified by procedure type into horses undergoing diagnostic imaging without surgical intervention, emergency or elective surgery. In addition, patients were grouped by opioid treatment regime into horses receiving no opioids, intraanaesthetic, short- (<24 h) or long-term (>24 h) postoperative opioids. Administered opioids encompassed butorphanol, morphine and methadone. The number of horses showing signs of colic in the 72 h after anaesthesia was assessed for each group. A total of 782 horses were included, comprising 659 undergoing surgical procedures and 123 undergoing diagnostic imaging. The overall PAC incidence was 15.1%. Notably, horses undergoing diagnostic imaging without surgery had a significantly lower PAC rate of 6.5% compared to those undergoing surgery (16.7%, p = 0.0146). Emergency surgeries had a significantly lower PAC rate of 5.8% compared to elective procedures (18%, p = 0.0113). Of the 782 horses, 740 received intraoperative opioids and 204 postoperative opioids, 102 of which long-term (≥24 h). Neither intraoperative (p = 0.4243) nor short-term postoperative opioids (p = 0.5744) increased PAC rates. Notably, only the long-term (≥24 h) administration of morphine significantly increased PAC incidence to 34% (p = 0.0038). In contrast, long-term butorphanol (5.3% PAC, p = 0.8482) and methadone (18.4% PAC, p = 0.6161) did not affect PAC rates. In summary, extended morphine administration was the only opioid treatment associated with a significantly increased risk of PAC.

Clinical and imaging findings, treatment details and outcomes in foals with extensor tendon rupture-A multicentre retrospective study

BACKGROUND

Forelimb extensor tendon rupture (ETR) in foals is sparsely documented.

OBJECTIVES

To describe clinical and imaging findings, treatment details, and long-term outcome in foals with ETR.

STUDY DESIGN

Multicentre retrospective case-series.

METHODS

Clinical record review of foals with ETR, presented to Faculty of Veterinary Medicine at Ghent University (Belgium), the Clinic for Horses at the University of Veterinary Medicine Hannover (Germany), and Rossdales Equine Hospital (UK) between 2009-2021. Long-term outcome based on structured telephone interview with the owner at the university hospitals and on future ratings from a public racing results archive at Rossdales Equine Hospital.

RESULTS

Eight foals (28%; 95%CI: 11.7%-44.3%) presented with ETR only, whereas 21 foals (72%; 95%CI: 55.7%-88.3%) presented with ETR and concurrent flexural limb deformity foals with ETR only were older (median 20 days; Interquartile range [IQR] 13-22) than foals with ETR and flexural limb deformity (median five days; IQR 3-11; p = 0.001). Treatment included medical support, immobilization, and box rest. Hospitalisation time was longer for foals with ETR and flexural limb deformity (median 26 days; IQR 16-44) than for ETR-only foals (median 11 days; IQR 6-16; p = 0.03). Total rehabilitation time was longer for foals with ETR and flexural limb deformity (median 58 days; IQR 42-91) than for foals without flexural limb deformity (median 32 days; IQR 12-39; p = 0.03). Six foals (21%; 95%CI: 6.3%-35.7%) were euthanased within seven months: three because of problems with limb protraction and progressive flexural limb deformity. Long-term follow-up (>18 months) was available for two cases with ETR only, and seven cases with ETR and flexural limb deformity. Both ETR-only foals had a positive cosmetic outcome but only one a positive functional outcome. Foals with ETR and concurrent flexural limb deformity suffered limitations regarding cosmetic appearance (5/7 negative) and limb function (7/7 negative).

MAIN LIMITATIONS

Small sample size, retrospective study, and no clinical follow-up.

CONCLUSIONS

ETR is a rare condition in this sample of foals treated under hospital conditions often requiring prolonged care, especially with concurrent flexural limb deformity. Further research should investigate potential associations with future athletic performance.